Our brands
Cizumab
Cizumab is an anticancer drug which contains Bevacizumab as composition, it is the first bevacizumab biosimilar in Indian market launched by Hetero exhibiting its strength of R&D in biotherapeutics space. It belongs to Anti Neoplastic therapy of Oncology Division and it is available in 2 forms: Cizumab 100Mg 4Ml Injection and Cizumab 400Mg Injection.
-
Cizumab 100Mg 4Ml Injection
Bevacizumab (100mg/4ml) -
Cizumab 400Mg Injection
Bevacizumab (400mg) -
CIZUMAB 300mg 12ml Injection
Bevacizumab 300 mg / 12 ml
subscribe
Quick Links
RESOURCES
Get in Touch
Copyright © All Rights Reserved by Hetero Healthcare Limited
